News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Opexa Therapeutics (OPXA) to Ring the NASDAQ Stock Market Closing Bell


5/24/2013 9:31:08 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

ADVISORY, May 24, 2013 (GLOBE NEWSWIRE) -- What: Opexa Therapeutics, Inc. [OPXA], a biotechnology company developing TcelnaTM, a patient specific T-cell immunotherapy for the treatment of multiple sclerosis (MS), will visit the NASDAQ MarketSite in Times Square. In honor of World MS Day, Neil K. Warma, President & Chief Executive Officer will ring the Closing Bell.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES